(RTTNews) - Fresenius Medical Care AG (FME.DE, FMS), a provider of kidney care products and services, on Tuesday reported lower profit for the third quarter of fiscal 2026, while revenue edged up from the previous year.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.